DIGNIFY THERAPEUTICS
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal cord injured, multiple sclerosis and similar patient populations. By combining novel pharmaceutical agents with drug delivery technology, Dignify Therapeutics will redefine the treatment of these disorders and restore the dignity of voluntary excretory function for these patients. The company was founded in 2013 and is headquartered in Raleigh, North Carolina.
DIGNIFY THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2013-01-01
Address:
Raleigh, North Carolina, United States
Country:
United States
Website Url:
http://www.dignifytherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
9199908561
Email Addresses:
[email protected]
Total Funding:
10.16 M USD
Technology used in webpage:
SPF SSL By Default Google Font API LetsEncrypt WordPress Domain Not Resolving Apache Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Investors List
Terry Engle
Terry Engle investment in Venture Round - Dignify Therapeutics
RA Capital Management
RA Capital Management investment in Venture Round - Dignify Therapeutics
Eshelman Ventures
Eshelman Ventures investment in Venture Round - Dignify Therapeutics
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Grant - Dignify Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - Dignify Therapeutics
Official Site Inspections
http://www.dignifytherapeutics.com Semrush global rank: 7.91 M Semrush visits lastest month: 410
- Host name: 50-87-146-167.unifiedlayer.com
- IP address: 50.87.146.167
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Dignify Therapeutics"
Dignify Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 9199908561 Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and …See details»
Dignify Therapeutics Executive Summary - National Institute of ...
Karl Thor, PhD Chief Scientific Officer [email protected] . www.dignifytherapeutics.com Ed Burgard, PhD President [email protected] . …See details»
Our Team - Dignify Therapeutics
Anthony DiTonno. CEO. Mr. DiTonno is a highly accomplished chief executive with 25+ years of senior leadership experience spanning the pharmaceutical, biotechnology, and medical device …See details»
Our Science - Dignify Therapeutics
Dignify Therapeutics is as a virtual drug development company focused on restoring voluntary control of excretory function to neurologically-impaired patients.See details»
Dignify Therapeutics - LinkedIn
Dignify Therapeutics | 565 followers on LinkedIn. We develop “on-demand” drugs that conveniently trigger the emptying of the bladder and/or bowel when the person wishes | Developer of novel ...See details»
Dignify Therapeutics 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Dignify Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Dignify Therapeutics Inc. Company Overview, Contact Details ...
Mar 1, 2019 Dignify Therapeutics Inc. attended event BIO CEO & Investor Conference on Feb 1st '25. RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2025 /PRNewswire/ - Dignify …See details»
DIGNIFY THERAPEUTICS, LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for DIGNIFY THERAPEUTICS, LLC of Research Triangle Park, NC. Get the latest business insights from …See details»
Dignify Therapeutics LLC
About Praxis Praxis is a Canadian-based not-for-profit organization that leads global collaboration in SCI research, innovation and care. ... NC 27709 [email protected] dignifytherapeutics.com …See details»
Dignify Therapeutics LLC - Drug pipelines, Patents, Clinical trials ...
Explore Dignify Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, 7 news, and 10 literature, Technology Platform:Chemical drugs, Synthetic peptide, Drug:DTI …See details»
Dignify Therapeutics LLC Executive Summary - National Institute of ...
[email protected]. www.dignifytherapeutics.com. DIGNIFY THERAPEUTICS, LLC • Mission statement: Dignify Therapeutics is focused on developing novel drug and medical …See details»
DIGNIFY THERAPEUTICS, INC. - VentureRadar
Website: http://www.dignifytherapeutics.com. Dignify Therapeutics develops bladder and bowel drug therapies for spinal cord-injured, multiple sclerosis and similar ...See details»
Dignify Therapeutics LLC | North Carolina Biotech Center
Dignify Therapeutics develops novel bowel and bladder therapies for people with neurological disorders and the elderly that suffer from incontinence.See details»
Dignify Therapeutics - Overview, News & Similar companies
Dignify Therapeutics contact info: Phone number: (919) 371-8138 Website: www.dignifytherapeutics.com What does Dignify Therapeutics do? Dignify Therapeutics …See details»
For Investors - Dignify Therapeutics
Dignify Therapeutics is dedicated to enhancing the quality of life for neurologically impaired people by re-establishing voluntary excretory function.See details»
Dignify Therapeutics Receives NIH Grant for Drug Development
Mar 22, 2023 Dignify Therapeutics, a pharmaceutical and medical device development company in Research Triangle Park, has received a major federal award to advance its main drug …See details»
Dignify Therapeutics Selected as a Praxis SCI Accelerate Company
Oct 22, 2024 Praxis is a Canadian-based not-for-profit organization that leads global collaboration in SCI research, innovation and care. We accelerate the translation of …See details»
Dignify to highlight recent accomplishments at the 2024 BIO …
Oct 16, 2024 RESEARCH TRIANGLE PARK, NC (October 15, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, announced that …See details»
Theratechnologies Receives FDA Approval for EGRIFTA WR™ …
New, improved formulation set to replace EGRIFTA SV ®. MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) …See details»
Dignify Therapeutics Highlights Clinical Development Plans at the …
Feb 14, 2025 Research Triangle Park, NC – February 14, 2025 – Dignify Therapeutics, a biotechnology company dedicated to restoring voluntary bowel and bladder function in patients …See details»